These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 29074637)
1. MR Elastography Analysis of Glioma Stiffness and Pepin KM; McGee KP; Arani A; Lake DS; Glaser KJ; Manduca A; Parney IF; Ehman RL; Huston J AJNR Am J Neuroradiol; 2018 Jan; 39(1):31-36. PubMed ID: 29074637 [TBL] [Abstract][Full Text] [Related]
2. Brain T1ρ mapping for grading and IDH1 gene mutation detection of gliomas: a preliminary study. Cao M; Ding W; Han X; Suo S; Sun Y; Wang Y; Qu J; Zhang X; Zhou Y J Neurooncol; 2019 Jan; 141(1):245-252. PubMed ID: 30414094 [TBL] [Abstract][Full Text] [Related]
3. Anatomical location differences between mutated and wild-type isocitrate dehydrogenase 1 in low-grade gliomas. Yu J; Shi Z; Ji C; Lian Y; Wang Y; Chen L; Mao Y Int J Neurosci; 2017 Oct; 127(10):873-880. PubMed ID: 27929688 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Yu J; Shi Z; Lian Y; Li Z; Liu T; Gao Y; Wang Y; Chen L; Mao Y Eur Radiol; 2017 Aug; 27(8):3509-3522. PubMed ID: 28004160 [TBL] [Abstract][Full Text] [Related]
5. IDH1 status is significantly different between high-grade thalamic and superficial gliomas. Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450 [TBL] [Abstract][Full Text] [Related]
6. Noninvasively evaluating the grading and IDH1 mutation status of diffuse gliomas by three-dimensional pseudo-continuous arterial spin labeling and diffusion-weighted imaging. Liu T; Cheng G; Kang X; Xi Y; Zhu Y; Wang K; Sun C; Ye J; Li P; Yin H Neuroradiology; 2018 Jul; 60(7):693-702. PubMed ID: 29777252 [TBL] [Abstract][Full Text] [Related]
7. The Value of Enhanced MR Radiomics in Estimating the IDH1 Genotype in High-Grade Gliomas. Niu L; Feng WH; Duan CF; Liu YC; Liu JH; Liu XJ Biomed Res Int; 2020; 2020():4630218. PubMed ID: 33163535 [TBL] [Abstract][Full Text] [Related]
8. Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI. Wang X; Chen XZ; Shi L; Dai JP Clin Radiol; 2019 Aug; 74(8):651.e7-651.e14. PubMed ID: 31014573 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features. Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745 [TBL] [Abstract][Full Text] [Related]
10. Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas. Wang Y; Zhang T; Li S; Fan X; Ma J; Wang L; Jiang T Eur J Neurol; 2015 Feb; 22(2):348-54. PubMed ID: 25318355 [TBL] [Abstract][Full Text] [Related]
11. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas. Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759 [TBL] [Abstract][Full Text] [Related]
12. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362 [TBL] [Abstract][Full Text] [Related]
13. Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation. Wang YY; Wang K; Li SW; Wang JF; Ma J; Jiang T; Dai JP AJNR Am J Neuroradiol; 2015 Nov; 36(11):2023-9. PubMed ID: 26316565 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of gliomas peritumoral diffusion and prediction of IDH1 mutation by IVIM-DWI. Gu T; Yang T; Huang J; Yu J; Ying H; Xiao X Aging (Albany NY); 2021 Mar; 13(7):9948-9959. PubMed ID: 33795525 [TBL] [Abstract][Full Text] [Related]
15. Prediction of Overall Survival Based on Isocitrate Dehydrogenase 1 Mutation and 18F-FDG Uptake on PET/CT in Patients With Cerebral Gliomas. Kim D; Kim S; Kim SH; Chang JH; Yun M Clin Nucl Med; 2018 May; 43(5):311-316. PubMed ID: 29485450 [TBL] [Abstract][Full Text] [Related]
16. GSH and GABA decreases in IDH1-mutated low-grade gliomas detected by HERMES spectral editing at 3 T in vivo. Gong T; Zhang X; Wei X; Yuan S; Saleh MG; Song Y; Edden RA; Wang G Neurochem Int; 2020 Dec; 141():104889. PubMed ID: 33115694 [TBL] [Abstract][Full Text] [Related]
17. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status. Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974 [TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of the diagnostic performance of Kim D; Chun JH; Kim SH; Moon JH; Kang SG; Chang JH; Yun M Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1678-1684. PubMed ID: 31102001 [TBL] [Abstract][Full Text] [Related]
19. Intravoxel incoherent motion magnetic resonance imaging in predicting IDH1 gene mutations in high-grade gliomas. Wang C; Dong H Acta Radiol; 2021 Oct; 62(10):1412-1417. PubMed ID: 33951927 [TBL] [Abstract][Full Text] [Related]
20. MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Zhou H; Vallières M; Bai HX; Su C; Tang H; Oldridge D; Zhang Z; Xiao B; Liao W; Tao Y; Zhou J; Zhang P; Yang L Neuro Oncol; 2017 Jun; 19(6):862-870. PubMed ID: 28339588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]